Gene Editing Might Alter Our DNA. It Might Destroy Our Humanity, Too.
By Mark Buchanan,
Bloomberg
| 11. 25. 2019
Biologists recently revealed a new form of the gene-editing tool known as Crispr that allows researchers to make precise changes to almost any element of DNA, permanently altering cellular biochemistry. It could help treat tens of thousands of diseases linked to variations in a single gene and lead to the creation of better antibiotics.
The latest development, called prime editing, is more accurate than older Crispr methods, which sometimes alter genomic DNA in the wrong places. The new method will be a boon to the least contentious kind of gene editing — gene therapy — which introduces genetic changes only within the body’s somatic or nonreproductive cells. One such method is already in clinical trials to treat Huntington’s disease, in which a genetic mutation leads to production of an abnormal protein in brain cells.
As gene-editing technology races ahead, scientists are agonizing over ethical issues. How, for example, can they ensure that treatments don’t cause more problems than they fix? Some genetic variants that seem clearly beneficial — lowering the risk of heart disease, for example — could have other...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...